209 related articles for article (PubMed ID: 28263937)
41. Effect of oral diuretics on chronic warfarin therapy: a retrospective study.
Edwards HD; Webb RD; Conway SE
Expert Opin Drug Saf; 2012 May; 11(3):375-80. PubMed ID: 21957964
[TBL] [Abstract][Full Text] [Related]
42. Hyperprothrombinemia as a result of a possible warfarin and intravaginal miconazole interaction.
Thomas JL; Dunn D; Pelletier A; Franks AS
South Med J; 2010 Oct; 103(10):1063-5. PubMed ID: 20802381
[TBL] [Abstract][Full Text] [Related]
43. Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
Prescrire Int; 2012 Feb; 21(124):33-6. PubMed ID: 22413715
[TBL] [Abstract][Full Text] [Related]
44. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
[TBL] [Abstract][Full Text] [Related]
46. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
Knudsen JF; Sokol GH
Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
[TBL] [Abstract][Full Text] [Related]
47. Leflunomide and warfarin interaction: case report and review of the literature.
Chonlahan J; Halloran MA; Hammonds A
Pharmacotherapy; 2006 Jun; 26(6):868-71. PubMed ID: 16716139
[TBL] [Abstract][Full Text] [Related]
48. Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies.
Perry SL; Samsa GP; Ortel TL
Thromb Haemost; 2005 Dec; 94(6):1196-202. PubMed ID: 16411394
[TBL] [Abstract][Full Text] [Related]
49. The Magnitude of the Warfarin-Amiodarone Drug-Drug Interaction Varies With Renal Function: A Propensity-Matched Cohort Study.
Miano TA; Yang W; Shashaty MGS; Zuppa A; Brown JR; Hennessy S
Clin Pharmacol Ther; 2020 Jun; 107(6):1446-1456. PubMed ID: 32112562
[TBL] [Abstract][Full Text] [Related]
50. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
[TBL] [Abstract][Full Text] [Related]
51. In Potential Stroke Patients on Warfarin, the International Normalized Ratio Predicts Ischemia.
Cao C; Martinelli A; Spoelhof B; Llinas RH; Marsh EB
Cerebrovasc Dis Extra; 2017; 7(2):111-119. PubMed ID: 28803231
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
Larsen TB; Rasmussen LH; Skjøth F; Due KM; Callréus T; Rosenzweig M; Lip GY
J Am Coll Cardiol; 2013 Jun; 61(22):2264-73. PubMed ID: 23562920
[TBL] [Abstract][Full Text] [Related]
53. Warfarin persistence among atrial fibrillation patients - why is treatment ended?
Björck F; Ek A; Johansson L; Själander A
Cardiovasc Ther; 2016 Dec; 34(6):468-474. PubMed ID: 27565120
[TBL] [Abstract][Full Text] [Related]
54. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
[TBL] [Abstract][Full Text] [Related]
55. Prevention of stroke in patients with atrial fibrillation.
Olsson SB; Halperin JL
Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
[TBL] [Abstract][Full Text] [Related]
56. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
[TBL] [Abstract][Full Text] [Related]
57. The potential drug-drug interaction between proton pump inhibitors and warfarin.
Henriksen DP; Stage TB; Hansen MR; Rasmussen L; Damkier P; Pottegård A
Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1337-40. PubMed ID: 26395871
[TBL] [Abstract][Full Text] [Related]
58. Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose.
Yasaka M; Oomura M; Ikeno K; Naritomi H; Minematsu K
Ann Hematol; 2003 Feb; 82(2):121-3. PubMed ID: 12601493
[TBL] [Abstract][Full Text] [Related]
59. Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation.
Nelson WW; Wang L; Baser O; Damaraju CV; Schein JR
Int J Clin Pharm; 2015 Feb; 37(1):53-9. PubMed ID: 25428444
[TBL] [Abstract][Full Text] [Related]
60. Warfarin compared with aspirin for older Chinese patients with stable coronary heart diseases and atrial fibrillation complications.
Liu X; Huang H; Yu J; Cao G; Feng L; Xu Q; Zhang S; Zhou M; Li Y
Int J Clin Pharmacol Ther; 2014 Jun; 52(6):454-9. PubMed ID: 24755126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
